beta
SLRX
Salarius Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
salarius is an oncology based biotechnology company developing targeted treatments for patients who need them the most.
Market Cap: 2.68 Million
Primary Exchange: NASDAQ
Website: http://www.flex-pharma.com/
Shares Outstanding: 3.94 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.29478625292253147
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 624 trading days
From: 2019-07-12 To: 2024-03-07
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|